• Paul Mueller posted Q2 net sales of $93.84 million, up 29.21% year over year, while net income slipped 1.81% to $11.42 million.
• Six-month net sales climbed 21.83% to $160.19 million; net income fell 17.14% to $13.72 million.
• Backlog was $206.95 million at June 30, down from $243.61 million at Dec. 31.
• Management cited strong pharma workload, a nearly full new module fabrication building, and a Dutch unit that more than doubled quarterly net income.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Paul Mueller Co. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607311730PRIMZONEFULLFEED9801767) on July 31, 2026, and is solely responsible for the information contained therein.